Eteplirsen Approved for Duchenne Muscular Dystrophy: The FDA Faces a Difficult Choice

Eteplirsen Approved for Duchenne Muscular Dystrophy: The FDA Faces a Difficult Choice

Molecular Therapy 24, 1884 (November 2016). doi:10.1038/mt.2016.188

Author: Cy A Stein

http://ift.tt/2h0EglI

In Vivo Gene Delivery to Lymph Node Stromal Cells Leads to Transgene-specific CD8+ T Cell Anergy in Mice

In Vivo Gene Delivery to Lymph Node Stromal Cells Leads to Transgene-specific CD8+ T Cell Anergy in Mice

Molecular Therapy 24, 1965 (November 2016). doi:10.1038/mt.2016.168

Authors: Séverine Ciré, Sylvie Da Rocha, Maxime Ferrand, Mary K Collins & Anne Galy

http://ift.tt/2gKwFcX

Type I Interferons Interfere with the Capacity of mRNA Lipoplex Vaccines to Elicit Cytolytic T Cell Responses

Type I Interferons Interfere with the Capacity of mRNA Lipoplex Vaccines to Elicit Cytolytic T Cell Responses

Molecular Therapy 24, 2012 (November 2016). doi:10.1038/mt.2016.161

Authors: Ans De Beuckelaer, Charlotte Pollard, Sandra Van Lint, Kenny Roose, Lien Van Hoecke, Thomas Naessens, Vimal Kumar Udhayakumar, Muriel Smet, Niek Sanders, Stefan Lienenklaus, Xavier Saelens, Siegfried Weiss, Guido Vanham, Johan Grooten & Stefaan De Koker

from Cancer via ola Kala on Inoreader http://ift.tt/2gKDzz2
via IFTTT

Dual Therapeutic Action of a Neutralizing Anti-FGF2 Aptamer in Bone Disease and Bone Cancer Pain

Dual Therapeutic Action of a Neutralizing Anti-FGF2 Aptamer in Bone Disease and Bone Cancer Pain

Molecular Therapy 24, 1974 (November 2016). doi:10.1038/mt.2016.158

Authors: Ling Jin, Yosuke Nonaka, Shin Miyakawa, Masatoshi Fujiwara & Yoshikazu Nakamura

from Cancer via ola Kala on Inoreader http://ift.tt/2h0F6Pv
via IFTTT

Eteplirsen Approved for Duchenne Muscular Dystrophy: The FDA Faces a Difficult Choice

Eteplirsen Approved for Duchenne Muscular Dystrophy: The FDA Faces a Difficult Choice

Molecular Therapy 24, 1884 (November 2016). doi:10.1038/mt.2016.188

Author: Cy A Stein

from Cancer via ola Kala on Inoreader http://ift.tt/2h0EglI
via IFTTT

GDF11 Protects against Endothelial Injury and Reduces Atherosclerotic Lesion Formation in Apolipoprotein E-Null Mice

GDF11 Protects against Endothelial Injury and Reduces Atherosclerotic Lesion Formation in Apolipoprotein E-Null Mice

Molecular Therapy 24, 1926 (November 2016). doi:10.1038/mt.2016.160

Authors: Wen Mei, Guangda Xiang, Yixiang Li, Huan Li, Lingwei Xiang, Junyan Lu, Lin Xiang, Jing Dong & Min Liu

from Cancer via ola Kala on Inoreader http://ift.tt/2h0KthA
via IFTTT

In This Issue

In This Issue

Molecular Therapy 24, 1886 (November 2016). doi:10.1038/mt.2016.189

from Cancer via ola Kala on Inoreader http://ift.tt/2h0DViS
via IFTTT